the deputy commissioner for human foods at the FDA, said during a Senate meeting this week, per NBC. According to the FDA, the agency has reviewed the safety of Red 3 —which is derived from ...
They use the same active ingredient, tirzepatide. The FDA said Thursday that “Lilly’s supply is currently meeting or exceeding demand,” after two years of shortages. Both drugs are part of ...
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
If Altimmune can't find a partner or be acquired, then a hefty fund raise awaits investors, which could hit the stock. Click ...
While generative artificial intelligence ("GenAI") has the potential to fundamentally change health care, it presents unique risks and ...
Verastem (VSTM) said the FDA has accepted for priority review its application for accelerated approval of its ...
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...
On November 20, the Company submitted written responses, including planned remediations where applicable for all deficiencies noted in the AIR, and requested a Submission Issue Request (SIR) meeting ...
15d
Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001Vertical integration of major ...
Kazia Therapeutics updates paxalisib's regulatory progress after FDA discussions on glioblastoma data, highlighting plans for ...
On December 17, 2024, the Company conducted a Submission Issue Request (SIR) meeting with the FDA. Management believes its comprehensive plans to address the Additional Information Request (AIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback